Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis
暂无分享,去创建一个
M. H. Poulsen | P. Vinholt | S. Sheikh | R. Hansen | Signe Hedengran Biørn | Johan Baden Birk‐Korch | Johan Baden Birk-Korch
[1] M. Roobol,et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. , 2021, European urology.
[2] Masanori Yamamoto,et al. Hematuria in Adults. , 2021, The New England journal of medicine.
[3] Z. Savin,et al. Flexible Cystoscopy in the Setting of Macroscopic Hematuria: Do the Findings Justify Its Use? , 2021, Urologia Internationalis.
[4] A. Elliott,et al. Nurse‐led one stop hematuria clinic: Outcomes from 2,714 patients , 2021, BJUI compass.
[5] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[6] K. Raza,et al. Does non-visible haematuria require urgent assessment? A retrospective cohort study from a university teaching hospital , 2021, World Journal of Urology.
[7] Y. Lotan,et al. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. , 2020, The Journal of urology.
[8] A. Alabousi,et al. The Diagnostic Yield of CT Urography in the Workup of Hematuria With Negative Cystoscopy , 2020, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[9] C. Hawks,et al. Ten‐year outcomes of the first ‘one‐stop haematuria clinic’ in an Australian public hospital , 2019, ANZ journal of surgery.
[10] Ahmed Abdelhafez. THE USEFULNESS OF PROSTATE SPECIFIC ANTIGEN SCREENING IN MALE PATIENTS PRESENTED WITH HAEMATURIA , 2019 .
[11] E. Messing,et al. Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. , 2019, European urology.
[12] Tove Faber Frandsen,et al. Searching for qualitative health research required several databases and alternative search strategies: a study of coverage in bibliographic databases. , 2019, Journal of clinical epidemiology.
[13] Y. Lotan,et al. Evaluation of Hematuria in a Large Public Health Care System , 2019, Bladder cancer.
[14] P. Davidson,et al. Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy. , 2019, The New Zealand medical journal.
[15] Ewout W Steyerberg,et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. , 2019, The Cochrane database of systematic reviews.
[16] P. Boström,et al. Progress towards a Nordic standard for the investigation of hematuria: 2019 , 2019, Scandinavian journal of urology.
[17] Bernard N. Kafor,et al. Haematuria in Benign, Prostatic Hyperplasia and Prostatic Carcinoma , 2019 .
[18] Bashar Mohammed Hobi,et al. Pioneer Data for Initiating Prostate Cancer National Screening Program in Baghdad , 2019, Indian Journal of Public Health Research & Development.
[19] H. Sørensen,et al. Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark , 2018, JAMA network open.
[20] N. Qi,et al. Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma , 2018, Cancer management and research.
[21] A. Feber,et al. Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. , 2018, European urology.
[22] N. Iqbal,et al. Clinicopathological Characteristics of Prostate Cancer in Patients Presenting to a Tertiary Care Private Sector Hospital. , 2018, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[23] M. Page,et al. Registration of systematic reviews in PROSPERO: 30,000 records and counting , 2018, Systematic Reviews.
[24] C. Obiorah,et al. The Role of Dutasteride in Acute Prostatic Haematuria , 2017 .
[25] A. Eisenhardt,et al. Haematuria work‐up in general care—A German observational study , 2017, International journal of clinical practice.
[26] S. Chan,et al. Differences in cancer characteristics of Chinese patients with prostate cancer who present with different symptoms. , 2016, Hong Kong medical journal = Xianggang yi xue za zhi.
[27] A. Charlett,et al. Study quality assessment tools , 2016 .
[28] W. Hamilton,et al. The association between symptoms and bladder or renal tract cancer in primary care: a systematic review. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.
[29] J. Patard,et al. Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome. , 2015, Urologic oncology.
[30] Jsa Green,et al. Quantifying the risk of malignancy in patients with visible haematuria presenting to the emergency department , 2015 .
[31] S. Horie,et al. Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer , 2014, International Journal of Clinical Oncology.
[32] Yiran Huang,et al. Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance , 2013, OncoTargets and therapy.
[33] Jan J Barendregt,et al. Meta-analysis of prevalence , 2013, Journal of Epidemiology & Community Health.
[34] S. Jacobsen,et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. , 2013, Mayo Clinic proceedings.
[35] Scott D. Miller,et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. , 2012, The Journal of urology.
[36] B. Somani,et al. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup. , 2012, The Journal of urology.
[37] S. Goonewardena,et al. Pattern of urological malignancies in 2010 – an audit from a tertiary referral centre , 2012 .
[38] L. Carmignani,et al. Hematuria One Stop Clinic: First Experience in Italy with 150 Cases , 2011, Urologia.
[39] N. Vasdev,et al. Has the introduction of the ‘2 week rule’ in the UK led to an earlier diagnosis of urological malignancy? , 2011, Ecancermedicalscience.
[40] K. Chan,et al. Three-Year Outcomes of a Visible Haematuria Clinic—No Initial Role for Urine Cytology? , 2010 .
[41] T. Badmus,et al. Burden of prostate cancer in southwestern Nigeria. , 2010, Urology.
[42] S. Chandrasekharan,et al. PSA Testing of Men in the Haematuria Clinic, a Useful Additional Test or Unnecessary Investigation , 2010 .
[43] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[44] T. Ebert,et al. Immunocytology in the assessment of patients with asymptomatic hematuria , 2008, World Journal of Urology.
[45] H. Samaratunga,et al. Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp , 2007, Pathology.
[46] K. Ghani,et al. COMPUTED TOMOGRAPHY UROGRAPHY FOR DIAGNOSING BLADDER CANCER , 2007, BJU international.
[47] D. Giannakis,et al. Multi-Detector row CT urography on a 16-row CT scanner in the evaluation of urothelial tumors , 2007, European Radiology.
[48] S. Payne,et al. The use of prostate‐specific antigen testing in men presenting with haematuria , 2006, BJU international.
[49] T. Peters,et al. Clinical features of prostate cancer before diagnosis: a population-based, case-control study. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.
[50] H. Hedelin,et al. Screening for bladder tumours in men aged 60–70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy , 2006, Scandinavian journal of urology and nephrology.
[51] P. Kincaid‐smith,et al. The investigation of hematuria. , 2005, Seminars in nephrology.
[52] Da-Lung Chen,et al. Hematuria: Analysis of 738 Outpatients , 2005 .
[53] N. Minkov,et al. Profuse haematuria , 2005, International Urology and Nephrology.
[54] C. Oranusi,et al. Cancer Of The Prostate: Experience At Nnewi, Southeast, Nigeria , 2004 .
[55] N. Dublin. Prostate biopsies--a retrospective review from the University Malaya Medical Center. , 2003, The Medical journal of Malaysia.
[56] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[57] Ingram Olkin,et al. Adjusting for publication bias in the presence of heterogeneity , 2003, Statistics in medicine.
[58] X. Gamé,et al. Comparison of red blood cell volume distribution curves and phase-contrast microscopy in localization of the origin of hematuria. , 2003, Urology.
[59] F. Buntinx,et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.
[60] P. D. Ekwere,et al. The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. , 2002, Journal of the National Medical Association.
[61] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[62] A. Rigby,et al. Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[63] I. Palacios,et al. Frequency of gross hematuria shortly after percutaneous coronary intervention. , 2001, The American journal of cardiology.
[64] R. Chahal,et al. Is It Necessary to Perform Urine Cytology in Screening Patients with Haematuria? , 2001, European Urology.
[65] K. Sugimura,et al. Microscopic hematuria as a screening marker for urinary tract malignancies , 2001, International journal of urology : official journal of the Japanese Urological Association.
[66] S. Holmäng,et al. The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up. , 2001, Scandinavian journal of urology and nephrology.
[67] S. Foley,et al. Haematuria; a late complication of TURP? , 2001, Prostate Cancer and Prostatic Diseases.
[68] D. Neal,et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. , 2000, The Journal of urology.
[69] K Koiso,et al. Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria , 1999, International journal of urology : official journal of the Japanese Urological Association.
[70] P. Walsh,et al. The epidemiology of prostate cancer in Jamaica. , 1998, Journal of Urology.
[71] F. Buntinx,et al. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. , 1997, Family practice.
[72] D. Osegbe. Prostate cancer in Nigerians: facts and nonfacts. , 1997, The Journal of urology.
[73] E. Millar,et al. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases , 1996, Histopathology.
[74] E. Messing,et al. Hematuria home screening: repeat testing results. , 1995, The Journal of urology.
[75] C. Lawton,et al. Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? , 1994, Radiology.
[76] R. Hiatt,et al. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[77] K. Miyake,et al. Etiology of asymptomatic microscopic hematuria in adults. , 1993, Hinyokika kiyo. Acta urologica Japonica.
[78] E. Messing,et al. Home screening for hematuria: results of a multiclinic study. , 1992, The Journal of urology.
[79] T. Igarashi,et al. Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. , 1990, The Journal of urology.
[80] B. C. Choi,et al. Microscopic haematuria as a predictor of urological diseases among steel workers. , 1990, The Journal of the Society of Occupational Medicine.
[81] M. Benson,et al. Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. , 1987, The Journal of urology.
[82] L. Melton,et al. Isolated asymptomatic microhematuria: a cross-sectional analysis of test-positive and test-negative patients. , 1987, Journal of general internal medicine.
[83] G. Kopelson,et al. Periurethral prostatic duct carcinoma. Clinical features and treatment results , 1978, Cancer.
[84] J. Seebode,et al. Biologic and pathophysiologic prognosticating indices in prostatic cancer. , 1978, The American surgeon.
[85] R. Carpenter,et al. Natural history of prostatic obstruction. A prospective survey. , 1969, The Journal of the Royal College of General Practitioners.